Brief: Allarity Therapeutics Appoints Three Biotechnology Executives To Board
24/07/2023 12:39
July 24 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS STRENGTHENS BOARD OF DIRECTORS WITH
APPOINTMENT OF THREE ACCOMPLISHED BIOTECHNOLOGY EXECUTIVES
* ALLARITY THERAPEUTICS: APPOINTMENT OF DIRECTORS EXPECTED
TO
BRING CO BACK INTO COMPLIANCE WITH NASDAQ STOCK MARKET'S
CONTINUED LISTING REQUIREMENTS
Source text for Eikon: ID:nGNX6vw2qX
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic